Toll Free Number Toll Free: 1800 103 1369 Email Us Email Us: customercare@canmoney.in

Markets

Market


Board Of Directors

You can view the Ratio Analysis for the last 5 years.



RATIOS

Krebs Biochemicals & Industries Ltd.

GO
Market Cap. ( ₹ in Cr. ) 123.97 P/BV -0.75 Book Value ( ₹ ) -76.64
52 Week High/Low ( ₹ ) 77/38 FV/ML 10/1 P/E(X) 0.00
Book Closure 27/09/2023 EPS ( ₹ ) 0.00 Div Yield (%) 0.00

ParticularsMar 26Mar 25Mar 24Mar 23Mar 22
Months1212121212
Source Of Info (AR = Annual Report, PR = Press Release)ARARARARAR
FaceValue10.0010.0010.0010.0010.00
      
PER SHARE RATIOS     
      
Basic EPS (Rs.)-7.85-12.49-9.16-11.30-20.81
Diluted EPS (Rs.)-7.85-12.49-9.16-11.30-20.81
Cash EPS (Rs.)-4.87-9.39-6.01-8.41-17.73
Book Value[Excl.RevalReserv]/Share (Rs.)-75.49-67.83-55.29-46.13-34.83
Book Value[Incl.RevalReserv]/Share (Rs.)-75.49-67.83-55.29-46.13-34.83
Revenue From Operations / Share (Rs.)11.0120.0923.3924.1827.69
PBDIT / Share (Rs.)-1.59-6.64-3.84-7.03-15.23
PBIT / Share (Rs.)-4.57-9.74-6.97-10.07-18.15
PBT / Share (Rs.)-7.85-12.49-9.15-11.45-20.65
Net Profit / Share (Rs.)-7.85-12.49-9.15-11.45-20.65
      
PROFITABILITY RATIOS     
      
PBDIT Margin (%)-14.42-33.06-16.40-29.07-55.00
PBIT Margin (%)-41.49-48.50-29.82-41.65-65.55
PBT Margin (%)-71.35-62.16-39.12-47.36-74.58
Net Profit Margin (%)-71.35-62.19-39.12-47.36-74.58
Return on Capital Employeed (%)-19.62-32.07-12.92-17.25-35.02
Return On Assets (%)-10.37-15.93-11.07-14.11-23.45
Long Term Debt / Equity (X)-0.20-0.21-0.44-0.43-0.03
Total Debt / Equity (X)-0.58-0.56-0.53-0.53-0.17
Asset Turnover Ratio (%)0.140.240.280.280.34
      
LIQUIDITY RATIOS     
      
Current Ratio (X)0.080.090.280.320.45
Quick Ratio (X)0.030.040.120.080.12
Inventory Turnover Ratio (X)4.045.470.490.812.19
      
COVERAGE RATIOS     
      
Interest Coverage Ratio (%)-0.48-2.42-1.76-5.10-6.09
Interest Coverage Ratio (Post Tax) (%)-1.39-3.56-3.21-7.30-7.26
      
VALUATION RATIOS     
      
Enterprise Value (Cr.)310.97356.07324.85304.75451.99
EV / Net Operating Revenue (X)13.108.226.445.857.57
EV / EBITDA (X)-90.82-24.86-39.27-20.10-13.76
MarketCap / Net Operating Revenue (X)3.633.322.612.335.18
Price / BV (X)-0.53-0.98-1.10-1.22-4.12
Price / Net Operating Revenue (X)3.643.322.612.335.18
EarningsYield-0.19-0.18-0.14-0.20-0.14